Skip to main content
Contact Us
Subscribe
E-Edition
74°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Healthy Returns
Recent news which mentions Healthy Returns
< Previous
1
2
Next >
Healthy Returns: Eli Lilly’s cholesterol pill impresses in mid-stage trial
November 19, 2024
Tags
Novartis AG
Health care industry
Dexcom Inc
From
CNBC.com News
Healthy Returns: AstraZeneca expands U.S. investment plan on confidence in economy
November 13, 2024
Tags
AstraZeneca PLC
Health care industry
Social issues
From
CNBC.com News
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
November 08, 2024
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
AstraZeneca PLC
From
CNBC.com News
Healthy Returns: Wegovy may reduce knee pain in patients with a type of arthritis and obesity
October 31, 2024
Tags
Health & Science
Healthy Returns
Health care industry
From
CNBC.com News
Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use
October 23, 2024
Tags
Amazon/com Inc
Microsoft Corp
Science
From
CNBC.com News
Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
October 15, 2024
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Healthy Returns
From
CNBC.com News
Healthy Returns: What activist Starboard's $1 billion stake means for Pfizer
October 08, 2024
Tags
Pfizer Inc
Biotech and Pharmaceuticals
Health care industry
From
CNBC.com News
Healthy Returns: Pfizer pulls sickle cell disease drug from markets – here’s why it matters
October 01, 2024
Tags
Social issues
Health care industry
Hacking
From
CNBC.com News
Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next
September 24, 2024
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
GSK plc
From
CNBC.com News
Healthy Returns: How competitive can Roche be in the weight loss drug market?
September 17, 2024
Tags
Social issues
Health care industry
Healthy Returns
From
CNBC.com News
Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs
September 10, 2024
Tags
Social issues
Health care industry
Healthy Returns
From
CNBC.com News
Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock
September 05, 2024
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Berkshire Hathaway Inc
From
CNBC.com News
Healthy Returns: What to know about the latest round of Pfizer, Moderna Covid vaccines
August 27, 2024
Tags
Biotech and Pharmaceuticals
Novavax Inc
Moderna Inc
From
CNBC.com News
Healthy Returns: The race to develop combination shots targeting Covid, flu is heating up
August 20, 2024
Tags
Social issues
Health care industry
Sanofi SA
From
CNBC.com News
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
August 14, 2024
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Eli Lilly and Co
From
CNBC.com News
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
August 06, 2024
Tags
Healthy Returns
Health & Science
Politics
From
CNBC.com News
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
July 31, 2024
Tags
Eli Lilly and Co
Zealand Pharma A/S
Biotech and Pharmaceuticals
From
CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
July 23, 2024
Tags
Johnson & Johnson
AstraZeneca PLC
Biotech and Pharmaceuticals
From
CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
July 16, 2024
Tags
Pfizer Inc
Eli Lilly and Co
Biotech and Pharmaceuticals
From
CNBC.com News
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
July 11, 2024
Tags
Health & Science
Healthy Returns
Health care industry
From
CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
July 03, 2024
Tags
Gilead Sciences Inc
UnitedHealth Group Inc
Health & Science
From
CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
June 26, 2024
Tags
Gilead Sciences Inc
Healthy Returns
Health & Science
From
CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
June 18, 2024
Tags
Health & Science
Healthy Returns
Labor economy
From
CNBC.com News
Healthy Returns: What we know about the next round of Covid vaccines
June 12, 2024
Tags
Novavax Inc
Biotech and Pharmaceuticals
Moderna Inc
From
CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
June 07, 2024
Tags
Science
Biotech and Pharmaceuticals
Eli Lilly and Co
From
CNBC.com News
Healthy Returns: Pfizer, Merck, J&J and more to release cancer drug data at industry conference
May 30, 2024
Tags
Merck & Co Inc
Health & Science
Healthy Returns
From
CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
May 21, 2024
Tags
Eli Lilly and Co
Science
Uber Technologies Inc
From
CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
May 14, 2024
Tags
Healthy Returns
Health & Science
Social issues
From
CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
May 07, 2024
Tags
Healthy Returns
Health & Science
Health care industry
From
CNBC.com News
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
May 01, 2024
Tags
Healthy Returns
Health & Science
CVS Health Corp
From
CNBC.com News
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.